Risk factor
Limited trading liquidity
Profitability factor
Very strong margins and returns
About
Revenio Group Oyj, a health technology company, designs, manufactures, and sells ophthalmic diagnostics and devices for the detection of glaucoma, macular degeneration, diabetic retinopathy, and cataracts in Finland, rest of Europe, and internationally. The company offers iCare IC100 and IC200 tonometers; iCare HOME, a device for self-measurement of eye pressure; imaging devices comprising iCare EIDON...
Company Valuation
From both historical and forecast perspectives, the stock is overpriced compared to similar stocks. In particular, the stock is overpriced on P/E, 'expensive' on EV/EBITD
Target Price
The average target price of REG1V.HE is 28 and suggests 36% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to incr
Buy
Sell